Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Spyre Therapeutics (SYRE) Q3 2016 Earnings
SYRE
8
Nov
Expected
Q1 2016
Q2 2016
Q3 2016
-177.42
-118.43
-59.43
-0.43
Details
Expected EPS
-0.55
Actual EPS
-0.47
Surprise EPS
0.08
Surprise Percent
+14.55%
Description
Spyre Therapeutics (SYRE) has reported earnings of -0.47 per share for Q3 2016.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login